Vesicare reduces muscle spasms of the bladder and urinary tract. Vesicare is used to treat symptoms of overactive bladder, such as frequent or urgent urination, and incontinence (urine leakage).
Vesicare is a muscarinic receptor antagonist. It works by blocking the action of certain chemicals in the body to help decrease urination problems caused by overactive bladder.
Astellas Pharma, Astellas and Teva said that, as a result of this settlement, the case is expected to be terminated by the consent judgment.
Additionally, settlement of the litigation provides Teva with the opportunity to launch a generic solifenacin succinate product in October, 2018, if Astellas does not obtain pediatric exclusivity.